Clinical Trials Sponsored by Fujian Longhua Pharmaceutical Co. Ltd

Total 3915 results

Tianjin Hemay Pharmaceutical Co., Ltd

Completed

Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis

Psoriasis

China
Shandong Luye Pharmaceutical Co., Ltd.
Nanjing Sike Pharmaceutical Co., Ltd.

Completed

Pharmacokinetics Study of Liposomal Paclitaxel in Humans (LPS-PK-H)

Cancer

China
Overseas Pharmaceuticals, Ltd.
Beijing Capton Pharmaceutical Technology Development Co., LTD

Not yet recruiting

An Open Label, Balanced, Randomized, Two-Treatment, Two-Period, Two-Sequence, Two-way Crossover, Oralcomparative Pharmacokinetic（PK）Study of Lacosamide Extended-Release Tablets , Adult, Human Subjects Under Fasting Conditions.

Epilepsy

China
Overseas Pharmaceuticals, Ltd.
Guangzhou Health Start Pharmaceutical Techology Co.,Ltd

Not yet recruiting

An Comparative Pharmacokinetic Study of Amlodipine Besylate Controlled-release Tablets,China in Normal, Healthy, Adult, Human Subjects Under Fasting Conditions

Hypertension

China
Xizang Haisco Pharmaceutical Co., Ltd

Recruiting

A Study for HSK39775 in Participants With Solid Tumors

Advanced Solid Tumors

China
Xizang Haisco Pharmaceutical Co., Ltd

Not yet recruiting

A Study of HSK21542 in a Peritoneal Dialysis Pruritus Population.

Pruritus
Tianjin Hemay Pharmaceutical Co., Ltd

Completed

Study Evaluating Hemay022 in Combination With Endocrine Therapy In Subjects With ER Positive and HER2 Positive Advanced Breast Cancer

Breast Cancer

China
Tianjin Hemay Pharmaceutical Co., Ltd

Terminated

Phase II Study of Hemay007 in Patients With Active Ulcerative Colitis

Ulcerative Colitis

China
Tianjin Hemay Pharmaceutical Co., Ltd

Completed

A Phase Ⅲ Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis

Psoriasis

China
Tianjin Hemay Pharmaceutical Co., Ltd

Completed

A Phase I Clinical Study of Hemay808

Safety Issues

China
Tianjin Hemay Pharmaceutical Co., Ltd

Recruiting

A Phase Ⅲ Study of Hemay022 in Combination With AI In Advanced Breast Cancer

Breast Cancer

China
Tianjin Hemay Pharmaceutical Co., Ltd

Completed

Multiple Ascending Dose Study to Assess Safety and Pharmacokinetics of Hemay005 In Healthy Subjects (Hemay005)

Psoriasis

China
Tianjin Hemay Pharmaceutical Co., Ltd

Completed

A Phase Ⅱ Study of Hemay808 for Atopic Dermatitis Patients

Atopic Dermatitis

China
Tianjin Hemay Pharmaceutical Co., Ltd

Completed

Study Evaluating Hemay022 In Subjects With HER2-Positive Advanced Breast Cancer

HER2 Positive Breast Cancer

China
Tianjin Hemay Pharmaceutical Co., Ltd

Terminated

A Study to Evaluate the Efficacy and Safety of Hemay005 in the Treatment of Behçet Disease

Behçet Disease

China
Jeil Pharmaceutical Co., Ltd.

Recruiting

To Evaluate the Safety, Pharmacokinetic Characteristics and the Effect of Food After Administration of JLP-2004

Healthy

Korea, Republic of
Qilu Pharmaceutical Co., Ltd.

Recruiting

A Study of QLG1074 Combined With Background Therapy in Subjects With Active Lupus Nephritis

Lupus Nephritis

China
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

A Study Comparing Pharmacokinetic and Safety of QL2109 and DARZALEX FASPRO® in Healthy Adults

Tumor

China
Biotech Pharmaceutical Co., Ltd.

Not yet recruiting

A Study of Nimotuzumab Plus Concurrent Chemoradiotherapy Sequential Maintenance Treatment for Cervical Carcinoma

Cervical Cancer
Simcere Pharmaceutical Co., Ltd

Not yet recruiting

Edaravone Dexborneol Sublingual Tablet for the PSCI in Acute Ischemic Stroke Patients

Post-stroke Cognitive Impairment

China
BioRay Pharmaceutical Co., Ltd.

Not yet recruiting

A Study of BRY805 in Participants With Advanced Solid Tumors

Advanced Solid Tumor

China
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

A Study to Compare the Pharmacokinetics and Safety of QL1101 and EU-Avastin® in Healthy Volunteers

Tumor

China
Ahon Pharmaceutical Co., Ltd.

Recruiting

A Trial to Evaluate the Efficacy and Safety of Methoxyetomidate Hydrochloride for Injection (ET-26) for the Induction of General Anesthesia in Elective Surgery Subjects

Anesthesia Induction

China
Daewoong Pharmaceutical Co. LTD.

Recruiting

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-Erosive Gastroesophageal Reflux Disease (NERD)

Non-erosive Reflux Disease | Non-Erosive Gastro-Esophageal Reflux Disease | Non-Erosive Esophageal Reflux Disease

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Recruiting

Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1567 in Healthy Adult Volunteers

Healthy Volunteers

Korea, Republic of
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

A Study of QL1706H in Patients With Advanced Solid Tumors

Advanced Solid Tumors
Otsuka Pharmaceutical Co., Ltd.

Recruiting

Food Effect Study of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia

Schizophrenia

Japan
BioRay Pharmaceutical Co., Ltd.

Not yet recruiting

Clinical Study of 1A46 Drug Substance

Advanced Malignancies

China
Biotech Pharmaceutical Co., Ltd.

Not yet recruiting

Safety and Preliminary Clinical Activity of Itolizumab in Dermatomyositis

Dermatomyositis, Adult Type
Daewoong Pharmaceutical Co. LTD.

Not yet recruiting

Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1543 With DWC202307 in Healthy Adult Volunteers

Healthy Volunteers
Daewoong Pharmaceutical Co. LTD.

Recruiting

To Evaluate the Efficacy and Safety of Envlo Tablet or Envlomet SR Tablet in Patients With Type II Diabetes Mellitus

Diabetes Mellitus, Type 2

Korea, Republic of
Ono Pharmaceutical Co. Ltd

Recruiting

A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy

Multiple System Atrophy (MSA)

United States
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

A Phase I Study of QLP2117 in Subjects With Advanced Solid Tumors

Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

A Phase I Study of QLS12004 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Biotech Pharmaceutical Co., Ltd.

Recruiting

Safety and Clinical Activity of Itolizumab in aGVHD

Acute Graft Versus Host Disease

China
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

A Study of Olanzapine in Patients With Acute Agitation

Acute Agitation
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

A Multicenter, Randomized, Double-blind Phase II Trial to Evaluate GM1 Prevention of Peripheral Neuropathy in Patients With Breast Cancer

To Evaluate the Effectiveness of GM1 in the Prevention of Albumin-paclitaxel Therapy Induced Peripheral Neuropathy in Breast Cancer Patients
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

A Study to Compare QLS1128 With Placebo in Symptomatic Participants With Mild to Moderate COVID-19

COVID-19

China
Daewoong Pharmaceutical Co. LTD.

Recruiting

To Compare the Safety and PK/PD Characteristics of Subjects With Between Hepatic Impairment and Normal Hepatic Function

Diabetes Mellitus, Type 2

Korea, Republic of
Otsuka Pharmaceutical Co., Ltd.

Recruiting

Samtasu Post-marketing General Drug Use-results Survey in Patients With Volume Overload in Heart Failure.

Heart Failure

Japan
Qilu Pharmaceutical Co., Ltd.

Recruiting

A Phase 2 Study to Evaluate the Efficacy and Safety of QLS1128 Orally in Symptomatic Participants With Mild to Moderate COVID-19

COVID-19

China
Daewoong Pharmaceutical Co. LTD.

Recruiting

Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia

Hypertension | Dyslipidemias

Korea, Republic of
Qilu Pharmaceutical Co., Ltd.

Recruiting

A Phase Ib/II Trial to Evaluate the Safety and Efficacy of QL1706 in Patients With Advanced Hepatocellular Carcinoma

Advanced Liver Cancer

China
Boryung Pharmaceutical Co., Ltd

Recruiting

An OS to Evaluate the Safety & Efficacy of Fixed Dose Combination Therapy With Atorvastatin and Ezetimibe (LITE)

Primary Hypercholesterolemia

Korea, Republic of
Qilu Pharmaceutical Co., Ltd.

Recruiting

A Phase II Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Cervical Cancer

Cervical Cancer

China
Qilu Pharmaceutical Co., Ltd.

Recruiting

Evaluating the Efficacy and Safety of QL0911 in the Prevention of Chemotherapy- Induced Thrombocytopenia

Chemotherapy-induced Thrombocytopenia

China
Qilu Pharmaceutical Co., Ltd.

Recruiting

To Evaluate the Efficacy of QLH11811 in Advanced NSCLC Patients With EGFR Mutation

Non-small Cell Lung Cancer

China
Ono Pharmaceutical Co. Ltd

Recruiting

A Study to Investigate the Safety, Tolerability, PK, PD, and Efficacy of ONO-7018 in Patients With R/R NHL or CLL

Lymphoma, Non-Hodgkin | Leukemia, Lymphocytic, Chronic, B-Cell

United States
Qilu Pharmaceutical Co., Ltd.

Recruiting

Safety, Tolerability and Pharmacokinetics Study of QLS31904 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Qilu Pharmaceutical Co., Ltd.

Recruiting

A Study of QLS1128 and in Combination With Ritonavir in Healthy Participants

COVID-19

China

3

Subscribe